Drugs / VBI-1901
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03382977 | Dec 2017 → Jul 2025 | glioblastoma | VBI Vaccines Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VBI-1901 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03382977 ↗ |